Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Regenxbio Inc.

Biological Products, (No Diagnostic Substances) · Rockville, MD, United States

  1. PrincipalsCraig MalzahnChief Technology OfficerCurran SimpsonChief Executive OfficerMitchell ChanChief Financial Officerand 3 more
  2. CompanyRegenxbio Inc.Rockville, MD, United States
  3. Phone line+1 (240) 552-8181General business
Request a quote

REGENXBIO Inc. is an SEC-registered Nasdaq-listed company (ticker RGNX) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 6

Chief executive

Curran SimpsonChief Executive Officer

Chair & board

Kenneth T. MillsDirector (Board)

Finance

Mitchell ChanChief Financial Officer

Technology & engineering

Craig MalzahnChief Technology Officer

Legal

Patrick J. ChristmasChief Strategy & Legal Officer
Everyone else on file (1)
Steve PakolaChief Medical Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Steve Pakola — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Craig Malzahn — Chief Technology Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Mitchell Chan — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Curran Simpson — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers